NCT05419869View on ClinicalTrials.gov

Pilot Decentralized Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

January 13, 2023

Study Completion Date

January 26, 2023

Conditions
Major Depressive Disorder
Interventions
DRUG

ALTO-100 PO Tablet

Two tablets daily

Trial Locations (2)

33134

Site 160, Coral Gables

39216

Site 156, Jackson

Sponsors

Lead Sponsor

Alto Neuroscience
All Listed Sponsors
lead

Alto Neuroscience

INDUSTRY